This article examines how MK-677’s GHS-R1a agonism drives IGF-1 axis elevation and PI3K/Akt/mTOR pathway activation in hippocampal neural progenitors and what preclinical models reveal about GH-independent neural plasticity mechanisms.

An examination of Selank heptapeptide modulation of GABA-A receptor subunit gene expression, enkephalin-degrading enzyme inhibition (neprilysin), and HPA axis normalization findings in preclinical anxiety-model research.

A research overview of Dihexa as an angiotensin IV analog, covering proposed HGF/c-Met receptor potentiation, dendritic spinogenesis findings in rodent models, and the substantial unknowns that remain before human relevance can be assessed.

A detailed scientific overview of the preclinical literature regarding Semax mechanisms.

A review of Noopept’s proposed AMPA receptor modulation characteristics and hippocampal long-term potentiation mechanisms in rodent preparations, examining how this differs from the neurotrophin pathway and the translational challenges bridging synaptic endpoint data to human cognition research.

An examination of Selank’s proposed immunomodulatory and neuroplasticity mechanisms, including IL-6 cytokine modulation, BDNF induction patterns in rodent models, and the enkephalin peptidase inhibition hypothesis.

A critical review of preclinical research on Noopept-associated neurotrophin mRNA upregulation in rodent hippocampus, analyzing the evidence for NGF and BDNF gene expression changes and the substantial gaps remaining in downstream TrkB and CREB pathway validation.

This article explores the preclinical effects of Semax on suppressing inflammatory transcriptomic shifts and cytokine expression in cerebral ischemia models.

A research-context overview of Epithalon’s proposed mechanisms involving telomerase reverse transcriptase expression, chromatin accessibility changes, and pineal gland melatonin pathway associations in aging cell models, with emphasis on mechanistic uncertainties and translational limitations.

A preclinical research summary of Semax-associated transcriptomic changes in rat MCAO models, including BDNF/NGF/TrkB upregulation and inflammatory gene suppression in ischemic cortex.